Advances in apheresis therapy for glomerular diseases

Area of Science:

• Nephrology
• Immunology
• Therapeutic Apheresis

Background:

• Circulating permeability factors from T cells are implicated in nephrotic syndrome proteinuria.
• Various glomerular diseases involve pathogenic antibodies or immune complexes.

Purpose of the Study:

• To review the immunomodulatory effects of apheresis in renal diseases.
• To assess the clinical evidence for apheresis efficacy in glomerulonephritis and other glomerular disorders.

Main Methods:

• Overview of apheresis techniques: Plasma Exchange (PE), Immunoadsorption Plasmapheresis (IAPP), Low-Density Lipoprotein Apheresis, Lymphocytapheresis (LCAP).
• Review of clinical evidence and randomized controlled studies for apheresis in primary and secondary glomerulonephritis.
• Analysis of apheresis application in antibody-mediated glomerular diseases.

Main Results:

• Apheresis methods effectively remove pathogenic factors and T cells implicated in renal diseases.
• Clinical evidence supports the efficacy of PE, IAPP, and LCAP in treating various glomerular conditions.
• Established recommendations for apheresis therapy in glomerular diseases based on recent studies.

Conclusions:

• Apheresis demonstrates significant immunomodulatory effects and clinical utility in managing renal diseases.
• Evidence supports the use of specific apheresis modalities for primary and secondary glomerulonephritis.
• Apheresis is a valuable therapeutic option for antibody-induced and immune-complex-mediated glomerular diseases.